Financial Metrics Unveiled: Mersana Therapeutics Inc (MRSN)’s Key Ratios in the Spotlight

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

The price of Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $3.53 in the last session, up 0.71% from day before closing price of $3.50. In other words, the price has increased by $0.71 from its previous closing price. On the day, 0.68 million shares were traded. MRSN stock price reached its highest trading level at $3.627 during the session, while it also had its lowest trading level at $3.49.


We take a closer look at MRSN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.77.

On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.

Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 16 ’24 when Protopapas Anna sold 29,399 shares for $2.71 per share. The transaction valued at 79,671 led to the insider holds 125,153 shares of the business.

Lowinger Timothy B sold 10,409 shares of MRSN for $28,208 on Jan 16 ’24. The SVP, Chief Sci.&Tech. Officer now owns 199,329 shares after completing the transaction at $2.71 per share. On Jan 16 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 9,327 shares for $2.71 each. As a result, the insider received 25,276 and left with 54,511 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 431322528 and an Enterprise Value of 252339104. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.70 while its Price-to-Book (P/B) ratio in mrq is 11.53. Its current Enterprise Value per Revenue stands at 6.847 whereas that against EBITDA is -1.489.

Stock Price History:

Over the past 52 weeks, MRSN has reached a high of $9.62, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -18.44%, while the 200-Day Moving Average is calculated to be 38.20%.

Shares Statistics:

According to the various share statistics, MRSN traded on average about 2.24M shares per day over the past 3-months and 1628500 shares per day over the past 10 days. A total of 120.71M shares are outstanding, with a floating share count of 92.78M. Insiders hold about 24.18% of the company’s shares, while institutions hold 70.58% stake in the company. Shares short for MRSN as of 1713139200 were 10580194 with a Short Ratio of 4.73, compared to 1710460800 on 8726183. Therefore, it implies a Short% of Shares Outstanding of 10580194 and a Short% of Float of 11.3800004.

Most Popular

[the_ad id="945"]